NM_003001.5:c.149G>T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_Strong
The NM_003001.5(SDHC):c.149G>T(p.Arg50Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000000685 in 1,460,316 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R50C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_003001.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SDHC | NM_003001.5 | c.149G>T | p.Arg50Leu | missense_variant | Exon 3 of 6 | ENST00000367975.7 | NP_002992.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460316Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 726632
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Gastrointestinal stromal tumor;C1854336:Paragangliomas 3 Uncertain:1
This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with an SDHC-related disease. In summary, this variant is a rare missense change with uncertain impact on protein function. While it is absent from the population and affects an amino acid residue important for protein function, the available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). A different missense substitution at this codon (p.Arg50Cys) has been determined to be likely pathogenic (PMID: 23175444, 27279923, 24102379, 19351833, 23666964, Invitae database). This suggests that the arginine residue is critical for SDHC protein function and that other missense substitutions at this position may also be pathogenic. This sequence change replaces arginine with leucine at codon 50 of the SDHC protein (p.Arg50Leu). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and leucine. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.R50L variant (also known as c.149G>T), located in coding exon 3 of the SDHC gene, results from a G to T substitution at nucleotide position 149. The arginine at codon 50 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at